
    
      Phase III clinical trial, systematic sampling, open-label study that evaluated the efficacy
      of the combination of mometasone furoate 0.1% and 5% salicylic acid in 71 patients with
      lesions of mild to moderate psoriasis treated for up to 45 days or less than this, at the
      discretion of the investigator. The results were statistically analyzed and investigational
      data and their conclusions are referred to in this report.
    
  